BPGAM
GILD icon

BTG Pactual Global Asset Management’s Gilead Sciences GILD Stock Holding History

BTG Pactual Global Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-73,400
Closed -$4.36M – 133
2022
Q1 		$4.36M Buy
+73,400
New +$4.69M 0.58% 68
2020
Q4 		– Sell
-125,000
Closed -$7.9M – 118
2020
Q3 		$7.9M Buy
+125,000
New +$8.67M 1.03% 36

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BTG Pactual Global Asset Management's GILD Position: Q2 2022 in Review

BTG Pactual Global Asset Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 5,748 shares — an estimated $342K sold.

BTG Pactual Global Asset Management first reported a position in GILD in Q4 2013 and held it in 15 quarters. The position peaked at $929K in Q2 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • BTG Pactual Global Asset Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 5,748 Gilead Sciences shares in Q2 2022, an estimated $342K.
  • BTG Pactual Global Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 15 quarters.
  • BTG Pactual Global Asset Management's Gilead Sciences position peaked at $929K in Q2 2017.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.